ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Real-world lecanemab adoption in Japan 1 year after launch: Insights from 311 specialists on infrastructure and reimbursement barriers.

Kenichiro Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.